Clorox Co. (CLX) Tops Q2 EPS by 12c, Tightens FY Guidance
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $106.69 +0.61%
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Clorox Co. (NYSE: CLX) reported Q2 EPS of $0.93, $0.12 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.27 billion.
Clorox Co. sees FY2013 EPS of $4.25-4.35, versus prior guidance of $4.20-4.35 and the consensus of $4.31.
For earnings history and earnings-related data on Clorox Co. (CLX) click here.
Clorox Co. sees FY2013 EPS of $4.25-4.35, versus prior guidance of $4.20-4.35 and the consensus of $4.31.
For earnings history and earnings-related data on Clorox Co. (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Investing.com’s stocks of the week
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
